A detailed history of Jpmorgan Chase & CO transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 47,074 shares of RMTI stock, worth $123,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,074
Previous 35 134397.14%
Holding current value
$123,804
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.67 - $4.4 $78,555 - $206,971
47,039 Added 134397.14%
47,074 $186,000
Q2 2022

Aug 11, 2022

BUY
$1.28 - $4.84 $44 - $169
35 New
35 $0

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $28.1M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.